HYTRIN Drug Patent Profile
✉ Email this page to a colleague
When do Hytrin patents expire, and what generic alternatives are available?
Hytrin is a drug marketed by Abbott and is included in two NDAs.
The generic ingredient in HYTRIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hytrin
A generic version of HYTRIN was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYTRIN?
- What are the global sales for HYTRIN?
- What is Average Wholesale Price for HYTRIN?
Summary for HYTRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 260 |
Clinical Trials: | 4 |
Patent Applications: | 4,727 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYTRIN at DailyMed |
Recent Clinical Trials for HYTRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Iowa | Phase 1 |
Michael J. Fox Foundation for Parkinson's Research | Phase 1 |
University of Iowa Institute of Clinical and Translational Sciences | Phase 1/Phase 2 |
US Patents and Regulatory Information for HYTRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-001 | Dec 14, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-004 | Dec 14, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HYTRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-002 | Aug 7, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HYTRIN
See the table below for patents covering HYTRIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 1100705 | ⤷ Sign Up | |
Denmark | 0623612 | ⤷ Sign Up | |
Australia | 498925 | ⤷ Sign Up | |
Sweden | 431208 | FORFARANDE FOR FRAMSTELLNING AV 2-(4-(TETRAHYDROPYRAN-2-KARBONYL)PIPERAZINYL)-4-AMINO-6,7-DIMETOXIKINAZOLIN | ⤷ Sign Up |
Mexico | 9306196 | NUEVA FORMA CRISTALINA POLIMORFA DE TERAZOSINA Y COMPOSICION FARMACEUTICA QUE LA CONTIENE. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |